Innovative Drug Delivery Systems: Pharmacological Approaches for Enhanced Therapeutic Outcomes

A drug delivery system (DDS) is a formulation or a device that allows a medicinal substance to be introduced into the body and enhances safety and efficacy by regulating the rate, location, and timing of drug release. The delivery of any therapeutic product, the product's release of the active chemicals, and the subsequent movement of the active components across cell membranes to the site that acts are all included in this process. An innovative drug delivery system combines cutting-edge methods with recently created dosage forms that are superior to traditional dosage forms. This chapter analyzes the types, principles, and pharmacological advantages of innovative delivery systems, such as controlled-release formulations, targeted delivery methods, and nanotechnology-based drivers (liposomes and nanoparticles). A major development in pharmacology, innovative drug delivery systems (IDDS) were created to solve the drawbacks of traditional techniques, including low bioavailability, widespread side effects, and low patient adherence. These systems maximize the absorption, distribution, metabolic processes, and elimination of drugs by combining the concepts of pharmacokinetics and pharmacodynamics. New platforms, such as targeted site-specific systems and nanocarriers, provide better safety profiles, lower dosage frequency, and more therapeutic precision. The stability, regulatory adherence, and toxicity issues with the formulation still exist, though. To better match treatments with patient needs, future trends indicate a move toward 3D bioprinting, AI-design drug delivery, gene delivery and individualized delivery systems. This chapter highlights the transformative significance of IDDS in enhancing therapeutic outcomes by synthesizing recent developments and new approaches in the field.